US 12060419
CD79A chimeric antigen receptors
granted A61KA61K39/395A61K39/44
Quick answer
US patent 12060419 (CD79A chimeric antigen receptors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/395, A61K39/44, A61K40/11, A61K40/31